aossa schreef:
Re: Question about Rhein Biotech-Answer some of my own questions
Rhein Biotech website says there are 4,104,892 shares outstanding, that would be an additional 4.75 million Crucell shares, bringing the total up to around 68 million shares. The 2006 PR below speaks of 9 million euro in sales, and 25 million euro in cash. Have both of these been rolled into Crucell's figures ofr 2006 and 2007?
www1.investorvillage.com/smbd.asp?mb=...[/quote]
Aossa, geen extra 4.75 mln CRXL shares, Crucell had namelijk reeds 92.7% van Rhein Biotech shares in haar bezit....
Zie Crucell's PB 16/11:
[quote]
Ownership of Rhein Biotech N.V. is currently divided between Berna Biotech AG in Switzerland, also fully owned by Crucell N.V., with a 92.7% holding, and external shareholders, who hold the remaining 7.3% of Rhein Biotech N.V. shares. Rhein Biotech N.V. will legally merge into Berna Rhein BV, a subsidiary in the Crucell group, against Crucell shares. The share capital of Crucell will be extended with 345,350 shares, which is less than 1% of the current outstanding share capital. It is expected that the merger will be effected before December 31, 2006.